• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
Aclaris Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), actual revenue USD 3.299M (forecast USD 1.405M), actual EPS USD -0.1191 (forecast USD -0.135)
04:00
Aclaris Therapeutics released FY2025 9-month earnings on November 6, 2025 (EST), with actual revenue of USD 6.531 M and actual EPS of USD -0.3691
04:00
Oct15
TR | OpenAI – 4o Downgrades Aclaris Therapeutics Rating to Sell
12:26
Amin Analyzes Healthcare Stocks, Giving Aclaris Therapeutics a Moderate Buy Rating
11:11
Oct14
Aclaris Therapeutics to Hold R&D Day to Showcase Innovative Therapies
11:43
Aug8
Aclaris Therap released FY2025 Semi-Annual earnings on August 7, 2025 (EST) with actual revenue of USD 3.232 M and EPS of USD -0.2491
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 3.299 M, Net Income -14.61 M, EPS -0.1191

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.777 M, Net Income -15.43 M, EPS -0.1258

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.455 M, Net Income -15.09 M, EPS -0.1232

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
17.850
+164.13%
+11.092
SMX
305.000
+116.31%
+159.000
GURE
8.080
+70.46%
+3.340
WHLR
5.420
+67.28%
+2.180
DBRG
13.774
+41.71%
+4.060
IRBT
4.280
+41.25%
+1.255
TDIC
0.3722
+32.55%
+0.091
ALMS
10.991
+32.42%
+2.691
TORO
5.400
+30.75%
+1.270
PRAX
247.215
+30.13%
+57.245
View More